Medtronic completes acquisition of SPR Therapeutics

{
  "signal_id": "aef50df4-0c56-ef47-00a0-97138190400d",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-07-16T14:30:26+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.pharmabiz.net/medtronic-completa-compra-de-spr-therapeutics/",
    "title": "Medtronic completes acquisition of SPR Therapeutics - pharmabiz.net",
    "excerpt": "Medical technology company Medtronic has completed the announced acquisition of SPR Therapeutics, a private company specializing in chronic pain treatments. The acquisition is valued at US$650M, including an upfront cash payment. The multinational led by Geoff Martha finalized the acquisition of SPR Therapeutics, a US medical technology company specializing in short-duration percutaneous peripheral nerve stimulation (PNS) therapies for the treatment of chronic and acute pain. The acquisition is valued at US$650 million, which includes an upfront cash payment. See Press Release. Chronic pain affects nearly 50 million American adults and, for some, can significantly impact their mobility, sleep quality, work performance, and overall quality of life. PNS is a form of neuromodulation that delivers gentle electrical stimulation near specific peripheral nerves to help reduce pain. As a non-opioid and non-surgical therapy, it can expand treatment options for pain management, facilitate earlier intervention in the care process, and help create additional opportunities for personalized patient care, Medtronic explained. Medtronic: plans to acquire SPR Therapeutics",
    "summary": "Medtronic has completed its acquisition of SPR Therapeutics, a private company specializing in chronic pain treatments, for $650 million.",
    "location": "United States",
    "planning": false,
    "image_url": "https://www.pharmabiz.net/wp-content/uploads/2024/04/MEDTRONIC2-e1731682181645.jpg",
    "confidence": 0.95,
    "published_at": "2026-07-16T14:30:26Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Medical technology company Medtronic has completed the announced acquisition of SPR Therapeutics, a private company specializing in chronic pain treatments.",
    "amount_normalized": 650000000,
    "related_company_name": "SPR Therapeutics",
    "related_company_domain": "sprtherapeutics.com"
  }
}

curl https://signals.autobound.ai/v1/signals/aef50df4-0c56-ef47-00a0-97138190400d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'